News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Filippo Alongi Shared Study on Real-World Safety and Feasibility of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients
Filippo Alongi
Jun 18, 2025, 15:32

Filippo Alongi Shared Study on Real-World Safety and Feasibility of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients

Filippo Alongi, Professor at University of Brescia, shared a post on X about his recent article, published in Cancers Journal:

“Our experience of optimal feasibility and no significant toxicity with 1.5 T MR-guided daily adapted RT in 1000 cases is now available in detail here.”

Title: The Clinical Feasibility and Safety of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients: A Real-World Large Experience of an Early-Adopter Center

Journal: Cancers

Authors: Chiara De-Colle, Michele Rigo, Andrea Gaetano Allegra, Luca Nicosia, Niccolò Giaj-Levra, Edoardo Pastorello, Francesco Ricchetti, Carolina Orsatti, Andrea Romei, Nicola Bianchi, Riccardo Filippo Borgese, Antonio De Simone, Davide Gurrera, Stefania Naccarato, Gianluisa Sicignano, Ruggero Ruggieri, Filippo Alongi

Read the full article.

Filippo Alongi

More posts featuring Filippo Alongi on OncoDaily.

Andrea Gaetano Allegra Andrea Romei Antonio De Simone cancer Cancers Journal Carolina Orsatti Chiara De-Colle Davide Gurrera Edoardo Pastorello Filippo Alongi Francesco Ricchetti Gianluisa Sicignano Luca Nicosia Michele Rigo Niccolò Giaj Levra Nicola Bianchi OncoDaily Oncology Riccardo Filippo Borgese Ruggero Ruggieri Stefania Naccarato University of Brescia
Special Coverage
Drugs
Jul 10, 2025, 01:19
Cisplatin in Cancer Treatment: Mechanism, Resistance, Toxicity, and Future Directions
Blog
Jul 9, 2025, 23:49
Sami Mansfield: Jumpstart July - Education plus Empowerment for Menopause After Cancer 
Insight
Jul 9, 2025, 23:06
Steven Rosenberg: The beginning of a new way to use immunotherapy
Blog
Jul 9, 2025, 22:10
Roland Busch: The busier the schedule, the more important the workout and discipline becomes
Blog
Jul 9, 2025, 21:45
Pierre Foidart: Honored to Receive Clinical Research Mandate from Stichting tegen Kanker - Fondation contre le Cancer
Blog
Jul 9, 2025, 21:20
Herbert Loong: Sarcomas Are a Group of Rare Diseases Which Benefits From Awareness and Specialist Care
Blog
Jul 9, 2025, 21:13
Asfand Yar Cheema: Calling All Internal Medicine Residents
Opinion
Jul 9, 2025, 21:08
Paolo Tarantino Opens the 3rd Annual ADC Toxicity Summit
Insight
Jul 9, 2025, 21:02
Marianna Vitaloni: I'm Incredibly Grateful to the Patients Who Shared Their Stories With Us
Blog
Jul 9, 2025, 20:28
Jennifer Guida: I Had the Privilege to Lead Pioneering Work at the NCI Focused on Cancer Survivorship, Healthy Aging, and Resilience
Blog
Jul 9, 2025, 20:27
Upcoming Global Cancer Research and Control Seminar Series - NCI Center for Global Health
Blog
Jul 9, 2025, 20:16
Rob Winn: Join for the Closing the Gap Cancer Summit